mRNA technology
Statistics report on the mRNA technology
This report presents a range of statistics and facts about the mRNA (messenger ribonucleic acid) technology. It is well-known to the broader public due to the COVID-19 vaccines from Moderna and BioNTech/Pfizer, which are mostly used in the Western world. The report provides a good starting point to get to know the mRNA landscape, including its position within biotech, top companies, short-term and long-term outlooks, etc.
Report Details
mRNA technology
Pages
38 Pages
Format
PPTX
,
PDF
Language
English
Released
2021
Access
Download from this page
Price
Old price: $495 USD New price: $345 USD
Comprehensive data insights
Includes all relevant statistics
Compiled by our industry experts
Table of contents
Overview
5
Basic
Statistic
Global pharmaceutical revenue by technology 2012-2026
Basic
Statistic
Percentage of global pharmaceutical sales by technology 2016-2030
Basic
Statistic
Leading pharma and biotech companies in 2024, by net sales growth
Basic
Statistic
Leading 50 global pharmaceutical and biotech companies 2024, by R&D intensity
Premium
Statistic
Forecasted revenue of mRNA market revenue worldwide 2021-2035
Research and development
5
Premium
Statistic
Global funding in mRNA therapeutics and vaccines 2015-2020
Premium
Statistic
Clinical pipeline of mRNA therapeutics worldwide by therapy area 2021
Basic
Statistic
Clinical pipeline of mRNA prophylactic vaccines worldwide by therapy area 2021
Basic
Statistic
Clinical pipeline of mRNA therapeutic vaccines worldwide by therapy area 2021
Premium
Statistic
mRNA technology clinical pipelines worldwide by therapy area and stage 2021
COVID-19
6
Basic
Statistic
Forecasted COVID-19 vaccine share of total mRNA revenues globally 2021-2035
Premium
Statistic
Forecasted COVID-19 vaccine revenue share globally by technology 2026
Basic
Statistic
Bestselling COVID-19 vaccines and drugs worldwide in 1st HY 2021
Basic
Statistic
Drugs generating 10 billion U.S. dollars or more in annual sales worldwide 2021
Basic
Statistic
Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
Premium
Statistic
COVID-19 vaccine development, enrollment and funding status July 28, 2020, by company
Leading companies
4
Premium
Statistic
Leading mRNA biotech companies' revenues 2022
Basic
Statistic
Leading mRNA biotech companies' net income 2022
Basic
Statistic
Leading mRNA biotech companies' R&D spending 2022
Basic
Statistic
Leading mRNA biotech companies' market cap 2026
Focus: Moderna
5
Basic
Statistic
Moderna's revenue 2016-2025
Basic
Statistic
Moderna net income 2016-2024
Basic
Statistic
R&D expenses of Moderna 2016-2024
Basic
Statistic
Moderna total assets 2016-2024
Basic
Statistic
Net Present Value of Moderna products worldwide 2021
Focus: BioNTech
4
Basic
Statistic
Revenue of BioNTech 2017-2025
Basic
Statistic
Operating income of BioNTech 2017-2024
Basic
Statistic
BioNTech earnings per share 2017-2024
Basic
Statistic
BioNTech total assets 2017-2025
FURTHER REPORTS
Recommended and recent reports
Recommended statistics
You may also be interested in...